Quanquan Gu launches Geodesic Intelligence to build AGI for drug discovery
DeryaTR_ · x · 2026-09-10
UCLA professor Quanquan Gu announced Geodesic Intelligence, an AI-native protein therapeutics startup aiming to build AGI for drug discovery — the "shortest path from biology to medicines."
- Combines frontier AI, biological foundation models, and experimental science in a full stack
- Launching today: NovaDDE and NovaAtom-Lite-Preview
The company says this is just the beginning.
Related event: UCLA's Quanquan Gu founds Geodesic to build AGI for drug discovery(4 posts)→
More from Companies & People
- SF 'Code Engineering' event picks up where 1,000-person harness engineering meetup left off — LangChain · 2026-10-27
- Anthropic reveals it bans customers worth 5-7% of revenue every 9 months — Polymarket · 2026-10-27
- Anthropic's IPO Filing Goes Public, Revealing Strong Revenue and Massive Spending — KateClarkTweets · 2026-10-27
- OpenAI Foundation funds UNC tumor antigen project, hiring senior experimental scientist — iskander · 2026-10-27
- Anthropic IPO timing fuels claims anti-open-weights panic is self-serving — mark_k · 2026-10-27
- Anthropic's S-1 reveals over half of $100K+ customers now use both Claude Platform and first-party apps — TechCrunch AI · 2026-10-27